abstract |
The present invention relates to a compound represented by the formula (I), a salt thereof, a solvate thereof, an N-oxide thereof or a prodrug thereof, which is a strong FXIa inhibitor, which is excellent in oral absorption and blood dynamics, and is orally A compound which exhibits strong anticoagulant activity after administration for a long period of time and which is separated from anticoagulant activity and CYP inhibitory activity, and thus can be a preventive and/or therapeutic agent for a useful thromboembolic disease.n□ (in the formula, all symbols are as described in the manual) |